Literature DB >> 11024037

Regulation of Cbl molecular interactions by the co-receptor molecule CD43 in human T cells.

G Pedraza-Alva1, S Sawasdikosol, Y C Liu, L B Mérida, M E Cruz-Muñoz, F Oceguera-Yañez, S J Burakoff, Y Rosenstein.   

Abstract

CD43, one of the most abundant glycoproteins on the T cell surface, has been implicated in selection and maturation of thymocytes and migration, adhesion, and activation of mature T cells. The adapter molecule Cbl has been shown to be a negative regulator of Ras. Furthermore, it may also regulate intracellular signaling through the formation of several multi-molecular complexes. Here we investigated the role of Cbl in the CD43-mediated signaling pathway in human T cells. Unlike T cell receptor signaling, the interaction of the adapter protein Cbl with Vav and phosphatidylinositol 3-kinase, resulting from CD43-specific signals, is independent of Cbl tyrosine phosphorylation, suggesting an alternative mechanism of interaction. CD43 signals induced a Cbl serine phosphorylation-dependent interaction with the tau-isoform of 14-3-3. protein. Protein kinase C-mediated Cbl serine phosphorylation was required for this interaction, because the PKC inhibitor RO-31-8220 prevented it, as well as 14-3-3 dimerization. Moreover, mutation of Cbl serine residues 619, 623, 639, and 642 abolished the interaction between Cbl and 14-3-3. Overexpression of Cbl in Jurkat cells inhibited the CD43-dependent activation of the mitogen-activated protein kinase (MAPK) pathway and AP-1 transcriptional activity, confirming nevertheless a negative role for Cbl in T cell signaling. However, under normal conditions, PKC activation resulting from CD43 engagement was required to activate the MAPK pathway, suggesting that phosphorylation of Cbl on serine residues by PKC and its association with 14-3-3 molecules may play a role in preventing the Cbl inhibitory effect on the Ras-MAPK pathway. These data suggest that by inducing its phosphorylation on serine residues, CD43-mediated signals may regulate the molecular associations and functions of the Cbl adapter protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11024037     DOI: 10.1074/jbc.M008494200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells.

Authors:  Nicholas Farley; Gustavo Pedraza-Alva; Diego Serrano-Gomez; Viswas Nagaleekar; Alexander Aronshtam; Troy Krahl; Tina Thornton; Mercedes Rincón
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

2.  Signaling through CD43 regulates CD4 T-cell trafficking.

Authors:  Purvi D Mody; Judy L Cannon; Hozefa S Bandukwala; Kelly M Blaine; Alexander B Schilling; Kevin Swier; Anne I Sperling
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

3.  Interaction of the CD43 Sialomucin with the Mycobacterium tuberculosis Cpn60.2 Chaperonin Leads to Tumor Necrosis Factor Alpha Production.

Authors:  Alvaro Torres-Huerta; Tomás Villaseñor; Angel Flores-Alcantar; Cristina Parada; Estefanía Alemán-Navarro; Clara Espitia; Gustavo Pedraza-Alva; Yvonne Rosenstein
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

4.  CD43 regulates the threshold for T cell activation by targeting Cbl functions.

Authors:  Gustavo Pedraza-Alva; Lilia B Mérida; Roxana del Rio; Nora A Fierro; Mario E Cruz-Muñoz; Norma Olivares; Erika Melchy; Vivian Igras; Georg A Holländer; Steven J Burakoff; Yvonne Rosenstein
Journal:  IUBMB Life       Date:  2011-09-09       Impact factor: 3.885

5.  CD43 is a ligand for E-selectin on CLA+ human T cells.

Authors:  Robert C Fuhlbrigge; Sandra L King; Robert Sackstein; Thomas S Kupper
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

6.  Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression.

Authors:  Ketki M Hatle; Wendy Neveu; Oliver Dienz; Stacia Rymarchyk; Ramiro Barrantes; Sarah Hale; Nicholas Farley; Karen M Lounsbury; Jeffrey P Bond; Douglas Taatjes; Mercedes Rincón
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

7.  Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.

Authors:  Catarina Sacristán; Stefan A Schattgen; Leslie J Berg; Stephen C Bunnell; Ananda L Roy; Yvonne Rosenstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

8.  Nlrp1b1 negatively modulates obesity-induced inflammation by promoting IL-18 production.

Authors:  Jonathan Salazar-León; Ana Laura Valdez-Hernández; Sara García-Jiménez; Luis Román-Domínguez; Enrique Huanosta-Murillo; Laura C Bonifaz; Leonor Pérez-Martínez; Gustavo Pedraza-Alva
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

9.  Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.

Authors:  Elena Odintsova; Guillaume van Niel; Hélène Conjeaud; Graça Raposo; Ryo Iwamoto; Eisuke Mekada; Fedor Berditchevski
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

10.  CD43 promotes cells transformation by preventing merlin-mediated contact inhibition of growth.

Authors:  Nohemi Camacho-Concha; Amiel Olivos-Ortiz; Alfredo Nuñez-Rivera; Adolfo Pedroza-Saavedra; Lourdes Gutierrez-Xicotencatl; Yvonne Rosenstein; Gustavo Pedraza-Alva
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.